Skip to main content
Caplight Logo









Lansik Inc.

Lansik Inc.

Private
SeoulHealthcare & Life Scienceshttps://glucofit.co.kr/en

Last Round

Pre Seed

Feb 27, 2024

Total Funding Raised

$960,000

Company Overview

Lansik Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Pre Seed round in February 2024.

Lansik Inc. is a digital healthcare company that operates Glucofit, an AI-powered blood glucose management platform that integrates continuous glucose monitoring with lifestyle data to provide personalized health insights.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Sports & Fitness, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Lansik Inc. Comparables

Compare Lansik Inc. with similar companies based on industry and business-model similarity.

Lansik Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kakao Corp.
83%
Pillyze
81%
Doctor Diary
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Lansik Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 27, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Lansik Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 122% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Lansik Inc. Filings

Explore SEC and related filing metadata, where available.

Lansik Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Lansik Inc.'s valuation, stock price, and market status.

Is Lansik Inc. a public or private company?

Lansik Inc. is a private company.

What is the current stock price of Lansik Inc.?

Lansik Inc. is a private company, so its shares have no public market price. Caplight tracks Lansik Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Lansik Inc. worth (valuation)?

Valuation information for Lansik Inc. is not publicly available.

Can I buy Lansik Inc. stock?

Lansik Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Lansik Inc.'s last funding round?

Lansik Inc.'s most recent funding round was Pre Seed on February 27, 2024.

Who are the main investors in Lansik Inc.?

Key investors in Lansik Inc. include BonAngels Venture Partners.

Will Lansik Inc. IPO soon?

No public IPO plans have been announced for Lansik Inc..

How can I track Lansik Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Lansik Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersSeoul
Employee Range4
Year Founded2022
Last FundingFeb 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?